Posted by Michael Wonder on 27 Oct 2022
Reference Committee for the health technology assessment policy and methods review
27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, health technology assessment and other matters with Medicines Australia acting on behalf of the innovator medicines industry (Strategic Agreement).
Under clause 5.3 of the Strategic Agreement, it was agreed that the Commonwealth would support and resource a Health Technology Assessment Policy and Methods Review.
